NCT04486924View on ClinicalTrials.gov

Performance and Safety of the Globe® Mapping and Ablation System With the GPS™ Module for the Treatment of Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 5, 2021

Primary Completion Date

August 30, 2022

Study Completion Date

August 30, 2022

Conditions
Atrial Fibrillation
Interventions
DEVICE

Globe Mapping and Ablation System

Prospective, non-randomized, open-label clinical study.

Trial Locations (2)

Unknown

Southlake Regional Health Centre, Newmarket

St. Paul's Hospital, Vancouver

Sponsors

Lead Sponsor

Kardium Inc.
All Listed Sponsors
lead

Kardium Inc.

INDUSTRY